PULMONARY EMBOLISM ACUTE MASSIVE
Clinical trials for PULMONARY EMBOLISM ACUTE MASSIVE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY EMBOLISM ACUTE MASSIVE trials appear
Sign up with your email to follow new studies for PULMONARY EMBOLISM ACUTE MASSIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New emergency drug shows promise for deadly lung clots with lower bleeding risk
Disease control Recruiting nowThis study is observing how well a new clot-dissolving drug works for patients with severe, life-threatening blood clots in the lungs (massive pulmonary embolism) during regular hospital care. It will track 20,000 patients who receive a single, weight-independent dose of the drug…
Matched conditions: PULMONARY EMBOLISM ACUTE MASSIVE
Sponsor: Supergene, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Race against time: new trial tests aggressive treatment for deadly lung clots
Disease control Recruiting nowThis study is testing whether adding an early, minimally invasive catheter procedure to standard emergency care can save more lives for people with a severe, life-threatening type of pulmonary embolism (a large blood clot in the lungs). It will compare the new approach to standar…
Matched conditions: PULMONARY EMBOLISM ACUTE MASSIVE
Phase: NA • Sponsor: Leipzig Heart Science gGmbH • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC